The US Food and Drug Administration identified a number of failures at the Glenmark Pharmaceuticals’ Bardez-based facility in Goa, creating drug formulations, in a warning letter sent to Glenmark Pharmaceuticals Chairman and Managing Director Glenn Saldanha. Investigators for the USFDA found a case where the company manually entered timed integration events into the processing techniques and reported successful findings without …
